Notch pathway: a journey from notching phenotypes to cancer immunotherapy

G Monticone, L Miele - Notch Signaling in Embryology and Cancer: Notch …, 2021 - Springer
Notch is a key evolutionary conserved pathway, which has fascinated and engaged the work
of investigators in an uncountable number of biological fields, from development of …

Understanding the journey of human hematopoietic stem cell development

A Kumar, SS D'Souza, AS Thakur - Stem cells international, 2019 - Wiley Online Library
Hematopoietic stem cells (HSCs) surface during embryogenesis leading to the genesis of
the hematopoietic system, which is vital for immune function, homeostasis balance, and …

Chemically-defined generation of human hemogenic endothelium and definitive hematopoietic progenitor cells

Y Chang, R Syahirah, SN Oprescu, X Wang, J Jung… - Biomaterials, 2022 - Elsevier
Human hematopoietic stem cells (HSCs), which arise from aorta-gonad-mesonephros
(AGM), are widely used to treat blood diseases and cancers. However, a technique for their …

Multilineage differentiation potential of hematoendothelial progenitors derived from human induced pluripotent stem cells

R Netsrithong, S Suwanpitak, B Boonkaew… - Stem Cell Research & …, 2020 - Springer
Background Human induced pluripotent stem cells (hiPSCs) offer a renewable source of
cells for the generation of hematopoietic cells for cell-based therapy, disease modeling, and …

Advances in adoptive cell therapy using induced pluripotent stem cell-derived T cells

R Netsrithong, M Wattanapanitch - Frontiers in immunology, 2021 - frontiersin.org
Adoptive cell therapy (ACT) using chimeric antigen receptor (CAR) T cells holds impressive
clinical outcomes especially in patients who are refractory to other kinds of therapy …

Generation of SIV-resistant T cells and macrophages from nonhuman primate induced pluripotent stem cells with edited CCR5 locus

SS D'Souza, A Kumar, J Weinfurter, MA Park, J Maufort… - Stem cell reports, 2022 - cell.com
Adoptive therapies with genetically modified somatic T cells rendered HIV resistance have
shown promise for AIDS therapy. A renewable source of HIV-resistant human T cells from …

Hematopoietic differentiation of human pluripotent stem cells: HOX and GATA transcription factors as master regulators

K Alsayegh, LV Cortés-Medina… - Current …, 2019 - ingentaconnect.com
Numerous human disorders of the blood system would directly or indirectly benefit from
therapeutic approaches that reconstitute the hematopoietic system. Hematopoietic stem …

Engineered T cells from induced pluripotent stem cells: from research towards clinical implementation

R Netsrithong, L Garcia-Perez, M Themeli - Frontiers in immunology, 2024 - frontiersin.org
Induced pluripotent stem cell (iPSC)-derived T (iT) cells represent a groundbreaking frontier
in adoptive cell therapies with engineered T cells, poised to overcome pivotal limitations …

An engineered multicellular stem cell niche for the 3D derivation of human myogenic progenitors from iPSCs

O Mashinchian, F De Franceschi, S Nassiri… - The EMBO …, 2022 - embopress.org
Fate decisions in the embryo are controlled by a plethora of microenvironmental interactions
in a three‐dimensional niche. To investigate whether aspects of this microenvironmental …

When CAR meets stem cells

JM Lee - International Journal of Molecular Sciences, 2019 - mdpi.com
The generation of immune cells from human pluripotent stem cells (embryonic stem cells
and induced pluripotent stem cells) has been of keen interest to regenerative medicine …